Is There an Over-the-Counter Treatment for Seborrheic Keratosis?

No FDA-approved over-the-counter product has been shown to reliably clear seborrheic keratoses. The only topical medication ever approved specifically for these growths was a prescription-strength 40% hydrogen peroxide solution, which is far more concentrated than anything you can buy at a pharmacy. That product has since been pulled from the market for commercial reasons, leaving dermatologists’ offices as the primary place where effective treatment happens. The gap between what people want (a cream or solution they can apply at home) and what actually works is wider than the marketing of various OTC “skin tag and mole removers” would have you believe.

The One Drug That Was Approved and What Happened to It

In 2017, the FDA approved a 40% hydrogen peroxide topical solution (brand name Eskata) for the treatment of raised seborrheic keratoses in adults. It was the first and, to date, only drug approved specifically for this condition.¹ The treatment was applied in a doctor’s office, not at home, and required precise application with a pen-like device to avoid damaging surrounding skin. Pooled data from the two pivotal trials showed that about 65% of facial seborrheic keratoses treated with the solution reached clear or near-clear status, compared to roughly 10% with a vehicle placebo. Truncal and extremity lesions responded at lower rates, around 46% and 38% respectively.²

Eskata was voluntarily withdrawn from the U.S. market in 2020 by its manufacturer, not because of safety problems but because of poor sales. The product occupied an awkward niche: it required an office visit and was expensive, yet many insurers classified seborrheic keratosis removal as cosmetic and refused to cover it. Patients who were already in the office could just as easily get cryotherapy or curettage, procedures dermatologists had been performing for decades. The result was a commercially unviable product, despite being the only one with an FDA indication for seborrheic keratoses.

A systematic review of topical treatments confirmed that hydrogen peroxide showed the strongest evidence for clearing seborrheic keratoses among all topical agents studied, though no head-to-head trials comparing it with cryotherapy or curettage existed.³ This means the gold standard for topical treatment was a 40% concentration, applied by a clinician, and it still did not clear every lesion. That context is important when evaluating anything you can buy without a prescription.

What OTC Products People Actually Try

Walk through the skincare aisle or browse online marketplaces and you will find products marketed for seborrheic keratoses containing ingredients like salicylic acid, glycolic acid, urea, or low-concentration hydrogen peroxide (the standard 3% drugstore bottle). None of these have been studied in rigorous clinical trials for seborrheic keratosis specifically, and none carry FDA approval for this use.

Salicylic acid and glycolic acid are keratolytic agents, meaning they break down the outermost layer of skin. At the concentrations available over the counter (typically 2% salicylic acid or up to 10% glycolic acid), they can soften rough or scaly patches, but seborrheic keratoses are structurally different from a simple callus or flaky patch. These growths involve thickened clusters of skin cells with distinct architectural features, and a mild keratolytic does not penetrate deeply enough to eliminate them. Higher concentrations of these acids, used in professional chemical peels, can remove the outer skin layer more aggressively,⁴ but those concentrations are not available OTC and carry their own risks when used without supervision.

The 3% hydrogen peroxide you can buy at a drugstore is roughly one-thirteenth the concentration of the prescription formulation that was approved. Dabbing it on a seborrheic keratosis is unlikely to do anything beyond mild fizzing. Some people report anecdotally that repeated applications over weeks or months produce mild flattening, but no clinical trial has demonstrated this, and you risk irritating the surrounding skin with no guarantee the lesion will respond.

Urea-based creams and lotions (commonly sold in 20-40% concentrations for dry, cracked skin) are another popular attempt. Urea is a good moisturizer and mild exfoliant, and it can make rough keratoses feel smoother. But “smoother” is not the same as “gone.” A systematic review noted urea-based solutions among topical agents that showed some response in small studies, but the evidence was thin compared to the hydrogen peroxide data.³

The Danger of Unregulated “Mole and Skin Tag Removers”

A more concerning category of products shows up online: concentrated pastes and liquids sold as “mole removers,” “skin tag removers,” or “wart removers” that people repurpose for seborrheic keratoses. Many contain concentrated salicylic acid, bloodroot extract (Sanguinaria canadensis), or other caustic chemicals. These are not FDA-approved for removing moles, skin tags, or seborrheic keratoses, and they can cause real harm.

An analysis of adverse events reported to the FDA and in consumer product reviews found that these unapproved topical removers were associated with burns, pain, ulceration, and in some cases permanent scarring and disfigurement.⁵ The products essentially work by chemically burning the skin, which is indiscriminate: they destroy the lesion and the healthy tissue around it. Worse, if the bump you are treating turns out not to be a seborrheic keratosis at all but something more serious, you have now damaged or destroyed the tissue a pathologist would need to make a proper diagnosis.

Bloodroot-containing products deserve special caution. Marketed under names that sound natural and gentle, bloodroot is a potent escharotic, meaning it kills tissue on contact. The resulting wound can be deep, slow to heal, and cosmetically far worse than the original bump. The FDA has explicitly warned consumers against using these products.

Why Getting the Diagnosis Right Comes First

One of the strongest arguments against self-treating any skin bump as a “harmless keratosis” is the real possibility of misdiagnosis. Seborrheic keratoses have a classic waxy, stuck-on appearance that experienced dermatologists recognize easily, but not every brown or rough-textured bump fits neatly into that category.

Melanoma can mimic seborrheic keratosis closely enough to fool even trained clinicians. An analysis of over 9,200 cases found that some melanomas share histological features with seborrheic keratoses, including the same patterns of thickened skin, darkened pigment, and warty surface texture that make keratoses look distinctive.⁶ Melanomas can also arise within or adjacent to existing seborrheic keratoses, further muddying the picture.⁷ Other malignant skin tumors are also misdiagnosed as seborrheic keratoses in clinical practice because of overlapping surface features.⁸

If a dermatologist can sometimes get it wrong, your chances of correctly diagnosing yourself from a bathroom mirror are not great. This matters because applying an OTC acid or caustic paste to a melanoma does not treat it. It merely damages the surface, potentially obscuring or delaying the diagnosis of a cancer that, caught early, is highly treatable but, caught late, can be fatal.

Smartphone Apps Are Not a Substitute

You might wonder whether AI-powered skin-checking apps close this gap. Current evidence suggests they do not, at least not reliably for seborrheic keratoses. One study testing a smartphone-based neural network on histologically confirmed lesions found that the algorithm’s sensitivity for correctly identifying seborrheic keratoses was only 0.52, meaning it missed about half of them. The same algorithm performed much better on melanomas and moles, but its weakness with keratoses is exactly the kind of gap that could lead to false reassurance or false alarm.⁹ These tools are improving, but relying on one to decide whether a bump is safe to self-treat is premature.

In-Office Treatments That Actually Clear Them

If seborrheic keratoses bother you cosmetically or catch on clothing and become irritated, the treatments with the best track records are all performed in a dermatologist’s office. The three workhorses are cryotherapy (freezing with liquid nitrogen), curettage (scraping with a small blade-like instrument), and laser treatment.

A prospective study comparing all three found that curettage achieved the highest clearance rate at about 88%, while cryotherapy and laser treatment were comparable at around 50-55%.¹⁰ An earlier study comparing cryotherapy and curettage noted that leftover lesion tissue occurred more often with cryotherapy, though both methods led to highly satisfactory cosmetic outcomes in patients’ eyes.¹¹

These procedures are quick, typically taking a few minutes per lesion, and recovery is straightforward. The catch, as many people searching for OTC alternatives already know, is cost. Insurance frequently classifies seborrheic keratosis removal as cosmetic, leaving patients to pay out of pocket. That financial barrier is a major reason people look for drugstore alternatives in the first place, and it is a legitimate frustration. But the gap between what an OTC product can do (very little, with real risks) and what a brief office procedure can do (reliably remove the lesion) remains wide.

When a Sudden Crop of Keratoses Deserves Urgent Attention

Most seborrheic keratoses accumulate gradually over years and are nothing more than a cosmetic nuisance. But a sudden eruption of many new seborrheic keratoses over a short period, sometimes called the sign of Leser-Trélat, can occasionally signal an internal malignancy. A systematic review found that among reported cases of eruptive seborrheic keratoses, about 76% of patients had a co-occurring cancer, with the eruptive keratoses preceding the cancer diagnosis by an average of four months. The most commonly associated cancers were cutaneous T-cell lymphoma and gastrointestinal adenocarcinoma.¹²

This association is rare, and the sign of Leser-Trélat is itself debated among dermatologists because seborrheic keratoses are so common in older adults that a coincidental increase can look dramatic. Still, the pattern matters: if you notice dozens of new keratoses appearing within weeks or a few months, especially if accompanied by other symptoms like unexplained weight loss or fatigue, that warrants a medical evaluation rather than a trip to the drugstore for a removal cream.

What Drives Seborrheic Keratoses in the First Place

Understanding why these growths appear helps explain why they are so stubborn against OTC treatments. Seborrheic keratoses are driven by genetic mutations in skin cells, most commonly in a gene called FGFR3. One study found FGFR3 mutations in 57% of seborrheic keratoses examined, and these mutations were present even in early, flat lesions, suggesting they are an initiating event rather than something that develops as the growth thickens.¹³ Other frequently mutated genes include PIK3CA and the TERT promoter, and the overall mutation pattern shows a UV-damage signature, with the types of DNA changes characteristic of long-term sun exposure.¹⁴

In other words, seborrheic keratoses are small, benign tumors, not just a buildup of dead skin. They grow from cells that have acquired mutations telling them to keep dividing. The cells in a seborrheic keratosis proliferate at a higher rate than normal skin regardless of which specific mutation is driving them.¹³ A keratolytic cream that dissolves surface skin does not reach or silence these mutations. That is why even the 40% hydrogen peroxide solution, which essentially destroyed the lesion tissue chemically, sometimes needed multiple applications and still failed to clear every growth. A topical agent has to do more than exfoliate; it has to eliminate a clonal population of mutated cells.

Where They Tend to Show Up and Why It Varies

Seborrheic keratoses can appear almost anywhere on the body except the palms and soles, but their distribution is not random. A retrospective study looking across different skin phototypes found that in lighter-skinned individuals (types 1 through 4), the back was the most common site, followed by the face and chest. In people with darker skin (types 5 and 6), the distribution shifted, with seborrheic keratoses appearing more frequently on the face.¹⁵

This matters for anyone considering treatment because location affects both the cosmetic impact and the treatment response. The pooled hydrogen peroxide trial data showed facial lesions responded substantially better than those on the trunk or extremities.² Similarly, adverse effects like discoloration after treatment were least common on the face and more frequent on the body. If you have keratoses primarily on your trunk or limbs, any topical approach, even a prescription one, is likely to be less effective than it would be for a facial lesion.

Dermatoscopic appearance also varies with skin type, which has implications for diagnosis. In darker skin, seborrheic keratoses can look very different from the textbook descriptions written for lighter skin, contributing to diagnostic uncertainty. If you have darker skin and are trying to self-identify a bump as a seborrheic keratosis based on online image searches, keep in mind that most reference photos skew heavily toward lighter skin tones and may not match what your lesion looks like.

Actinic Keratosis Is the One That Does Have OTC-Adjacent Options

Part of the confusion around OTC treatment may stem from mixing up seborrheic keratosis with actinic keratosis. The names sound similar, but these are fundamentally different conditions. Actinic keratoses are rough, scaly patches caused by UV damage that are considered precancerous, with a small percentage progressing to squamous cell carcinoma if left untreated. Seborrheic keratoses, despite sometimes harboring UV-signature mutations, are benign and do not become skin cancer.¹⁶

Actinic keratoses have several prescription topical treatments, including fluorouracil cream, imiquimod, and diclofenac gel, all of which are applied at home over weeks. Because actinic keratoses involve abnormal but less structurally complex cell growth near the skin surface, topical chemotherapy agents can reach and destroy the affected cells. Seborrheic keratoses are thicker, more architecturally complex growths, and none of those prescription topicals are indicated for them. If someone told you they “used a cream to get rid of their keratosis,” they were almost certainly treating an actinic keratosis, not a seborrheic one. The distinction matters if you are shopping for solutions based on someone else’s experience.